Baillie Gifford & CO Twist Bioscience Corp Transaction History
Baillie Gifford & CO
- $131 Billion
- Q3 2024
A detailed history of Baillie Gifford & CO transactions in Twist Bioscience Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 834,339 shares of TWST stock, worth $36.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
834,339
Previous 984,302
15.24%
Holding current value
$36.4 Million
Previous $48.5 Million
22.29%
% of portfolio
0.03%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding TWST
# of Institutions
257Shares Held
66.6MCall Options Held
127KPut Options Held
45.4K-
Artisan Partners Limited Partnership Milwaukee, WI6.02MShares$262 Million0.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$245 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$236 Million0.01% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.36MShares$234 Million2.3% of portfolio
-
Invesco Ltd. Atlanta, GA3.64MShares$159 Million0.03% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.46B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...